6294-51-5 Usage
General Description
5-Amino-thiazole-2-thiol is a chemical compound that belongs to the family of thiazoles, which are heterocyclic compounds with a ring structure consisting of two carbon atoms, a nitrogen atom and a sulfur atom. It is a derivative of thiazole and has a thiol group (-SH) and an amino group (-NH2) attached to the thiazole ring. 5-AMino-thiazole-2-thiol can be used in the synthesis of various pharmaceuticals and biologically active compounds. Its properties such as molecular weight, melting and boiling points, stability, solubility and others are influenced by the presence of sulfur and nitrogen in its molecular structure. The exact effects and applications of 5-Amino-thiazole-2-thiol can vary depending on its interactions with other substances or compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 6294-51-5 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,2,9 and 4 respectively; the second part has 2 digits, 5 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 6294-51:
(6*6)+(5*2)+(4*9)+(3*4)+(2*5)+(1*1)=105
105 % 10 = 5
So 6294-51-5 is a valid CAS Registry Number.
InChI:InChI=1/C3H4N2S2/c4-2-1-5-3(6)7-2/h1H,4H2,(H,5,6)
6294-51-5Relevant articles and documents
SULFONYL COMPOUNDS THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN
-
Page/Page column 138, (2013/08/28)
The present invention relates to sulfonyl compounds that interact with glucokinase regulatory protein. In addition, the present invention relates to methods of treating type 2 diabetes, and other diseases and/or conditions where glucokinase regulatory protein is involved using the compounds, or pharmaceutically acceptable salts thereof, and pharmaceutical compositions that contain the compounds, or pharmaceutically acceptable salts thereof.
7-OXO-THIAZOLOPYRIDINE CARBONIC ACID DERIVATIVES AND THEIR USE IN THE TREATMENT, AMELIORATION OR PREVENTION OF A VIRAL DISEASE
-
Paragraph 0191-0192, (2013/12/04)
The present invention relates to a compound having the general formula (A), optionally in the form of a pharmaceutically acceptable salt, solvate, polymorph, codrug, cocrystal, prodrug, tautomer, racemate, enantiomer, or diastereomer or mixture thereof, which are useful in treating, ameloriating or preventing a viral disease. Furthermore, specific combination therapies are disclosed.
